TIMP1 and breast adenocarcinoma: The ability of PEG20K-TIMP-1 to inhibit MMP-dependent cancer cell invasion was evaluated in Matrigel transwell assays using MDA-MB-231 cells, a highly invasive cell line derived from a metastatic breast adenocarcinoma.